Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-02-21 00:43 | 2013-02-19 | MMM | 3M CO | Bushman Julie L | Officer | OPT+S | $104.24 | 30,330 | $3,161,648 | 16,668 |
| 2013-02-21 02:06 | 2013-02-19 | MMM | 3M CO | PALENSKY FRED J | Officer | OPT+S | $104.03 | 75,439 | $7,847,927 | 34,072 |
| 2013-02-20 16:39 | 2013-02-15 | BDX | BECTON DICKINSON & CO | Sichak Stephen | Officer | OPT+S | $88.34 | 2,937 | $259,455 | 7,355 |
| 2013-02-20 01:25 | 2013-02-14 | HAE | HAEMONETICS CORP | Kelly Michael P | Officer | OPT+S | $41.71 | 1,400 | $58,394 | 11,736 |
| 2013-02-16 02:00 | 2013-02-14 | ANGO | Angiodynamics Inc. | BUCCI VINCENT | Director | BUY | $12.17 | 2,000 | $24,332 | 38,696 |
| 2013-02-16 00:57 | 2013-02-13 | GMED | GLOBUS MEDICAL INC | Demski David M | Director, Officer | SELL | $15.00 | 25,775 | $386,625 | 815,590 |
| 2013-02-14 03:28 | 2013-02-13 | ARAY | Accuray Incorporated | LEVINE JOSHUA | Officer | BUY | $4.38 | 100,000 | $437,890 | 300,000 |
| 2013-02-12 21:48 | 2013-02-11 | BDX | BECTON DICKINSON & CO | ORR JAMES F | Director | OPT+S | $88.28 | 4,436 | $391,610 | 19,608 |
| 2013-02-08 19:36 | 2013-02-06 | BDX | BECTON DICKINSON & CO | Conroy Alexandre | Officer | OPT+S | $87.81 | 11,392 | $1,000,279 | 10,264 |
| 2013-02-08 19:27 | 2013-02-06 | BDX | BECTON DICKINSON & CO | Boles Donna M | Officer | OPT+S | $87.59 | 3,201 | $280,376 | 14,607 |
| 2013-02-08 19:18 | 2013-02-07 | BDX | BECTON DICKINSON & CO | SHERMAN JEFFREY S | Officer | OPT+S | $87.30 | 16,301 | $1,423,077 | 25,176 |
| 2013-02-09 00:21 | 2013-02-07 | BAX | BAXTER INTERNATIONAL INC | STALLKAMP THOMAS T | Director | OPT+S | $68.66 | 5,680 | $389,989 | 3,314 |
| 2013-02-07 17:37 | 2013-02-05 | SYK | STRYKER CORP | Scannell Timothy J | Officer | OPT+S | $62.79 | 1,200 | $75,348 | 26,206 |
| 2013-02-08 04:05 | 2013-02-05 | RMD | RESMED INC | PENDARVIS DAVID | Officer | SELL | $44.40 | 0 | $20 | 65,717 |
| 2013-02-07 22:35 | 2013-02-06 | BDX | BECTON DICKINSON & CO | KOZY WILLIAM A | Officer | OPT+S | $87.56 | 22,923 | $2,007,138 | 101,090 |
| 2013-02-07 00:09 | 2013-02-04 | RMD | RESMED INC | Douglas Robert Andrew | Officer | OPT+S | $44.14 | 8,000 | $353,113 | 99,331 |
| 2013-02-06 00:08 | 2013-02-04 | SYK | STRYKER CORP | Owen Katherine Ann | Officer | BUY | $62.42 | 470 | $29,337 | 5,020 |
| 2013-02-05 20:35 | 2013-02-01 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | OPT+S | $41.96 | 13,000 | $545,466 | 116,286 |
| 2013-02-06 01:38 | 2013-02-01 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | SELL | $15.08 | 9,000 | $135,702 | 832,889 |
| 2013-02-05 00:47 | 2013-02-01 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | OGRADY JUDITH | Officer | SELL | $42.58 | 1,000 | $42,584 | 23,674 |
| 2013-02-02 03:20 | 2013-01-30 | RMD | RESMED INC | QUINN MICHAEL A | Director | OPT+S | $47.75 | 3,000 | $143,250 | 302,000 |
| 2013-02-02 03:21 | 2013-01-30 | RMD | RESMED INC | FARRELL PETER C | Director, Officer | OPT+S | $46.98 | 400,000 | $18,790,800 | 620,916 |
| 2013-02-02 00:19 | 2013-02-01 | BAX | BAXTER INTERNATIONAL INC | Shapazian Carole J | Director | SELL | $68.43 | 2,540 | $173,812 | 5,429 |
| 2013-02-01 03:17 | 2013-01-29 | RMD | RESMED INC | Farrell Michael J. | Officer | OPT+S | $47.32 | 8,000 | $378,560 | 86,796 |
| 2013-02-01 01:04 | 2013-01-30 | GMED | GLOBUS MEDICAL INC | Murphy A Brett | Officer | SELL | $12.87 | 31,103 | $400,296 | 121,217 |
| 2013-01-31 02:10 | 2013-01-28 | RMD | RESMED INC | WAREHAM JOHN P | Director | OPT+S | $48.20 | 36,000 | $1,735,200 | 13,000 |
| 2013-01-29 22:50 | 2013-01-18 | ARAY | Accuray Incorporated | Londy Kelly | Officer | BUY | $5.26 | 100 | $526 | 73,253 |
| 2013-01-30 00:21 | 2013-01-28 | BAX | BAXTER INTERNATIONAL INC | HANTSON LUDWIG | Officer | SELL | $67.64 | 10,500 | $710,220 | 87,005 |
| 2013-01-26 01:23 | 2013-01-25 | MRIC | ClearPoint Neuro, Inc. | Malernee James K. Jr. | Director | BUY | $0.00 | 100,000 | $0 | 290,659 |
| 2013-01-26 01:17 | 2013-01-25 | MRIC | ClearPoint Neuro, Inc. | Conway Bruce C. | Director | BUY | $0.00 | 100,000 | $0 | 2,023,883 |
| 2013-01-26 01:19 | 2013-01-25 | MRIC | ClearPoint Neuro, Inc. | SPENCER JOHN N JR | Director | BUY | $0.00 | 10,000 | $0 | 56,433 |
| 2013-01-26 01:21 | 2013-01-25 | MRIC | ClearPoint Neuro, Inc. | PIETRANGELO MICHAEL | Director | BUY | $0.00 | 125,000 | $0 | 297,169 |
| 2013-01-17 00:17 | 2013-01-14 | HAE | HAEMONETICS CORP | Kelly Michael P | Officer | OPT+S | $42.29 | 1,400 | $59,211 | 11,736 |
| 2013-01-14 20:07 | 2013-01-11 | ANGO | Angiodynamics Inc. | Gould Kevin J | Director | BUY | $11.58 | 2,700 | $31,277 | 8,250 |
| 2013-01-09 01:16 | 2013-01-04 | HAE | HAEMONETICS CORP | ALLEN PETER M | Officer | OPT+S | $41.62 | 53,288 | $2,217,815 | 26,346 |
| 2013-01-09 01:17 | 2013-01-07 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | OPT+S | $41.47 | 13,000 | $539,172 | 116,286 |
| 2013-01-09 01:17 | 2013-01-04 | HAE | HAEMONETICS CORP | HANLON SUSAN M | Officer | OPT+S | $41.66 | 10,000 | $416,570 | 16,506 |
| 2013-01-05 00:24 | 2013-01-02 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | OGRADY JUDITH | Officer | SELL | $39.63 | 1,000 | $39,630 | 24,674 |
| 2013-01-05 00:49 | 2013-01-02 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | SELL | $13.89 | 9,000 | $125,010 | 841,889 |
| 2013-01-05 00:21 | 2013-01-02 | BAX | BAXTER INTERNATIONAL INC | Baughman Michael J | Officer | OPT+S | $67.35 | 24,500 | $1,650,075 | 27,478 |
| 2013-01-03 19:31 | 2012-12-31 | SNWV | SANUWAVE Health, Inc. | Nemelka David Nephi Jr. | 10% owner | SELL | $0.25 | 909,523 | $227,381 | 0 |
| 2013-01-03 23:56 | 2012-10-05 | MMM | 3M CO | PALENSKY FRED J | Officer | OPT+S | $94.60 | 29,737 | $2,813,120 | 34,580 |
| 2013-01-03 19:03 | 2013-01-02 | ICUI | ICU MEDICAL INC/DE | SAUCEDO JOSEPH R | Director | SELL | $61.06 | 4,875 | $297,668 | 0 |
| 2013-01-04 04:30 | 2012-12-31 | ARAY | Accuray Incorporated | Londy Kelly | Officer | SELL | $6.28 | 2,547 | $15,995 | 73,153 |
| 2013-01-02 21:15 | 2012-12-27 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $54.69 | 27,000 | $1,476,757 | 12,589,682 |
| 2012-12-27 03:42 | 2012-12-24 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $55.70 | 18,000 | $1,002,661 | 12,616,682 |
| 2012-12-21 22:39 | 2012-12-20 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $56.02 | 18,000 | $1,008,292 | 12,634,682 |
| 2012-12-22 02:20 | 2012-12-19 | CYTX | PLUS THERAPEUTICS, INC. | HEDRICK MARC H | Director, Officer | BUY | $2.85 | 10,000 | $28,500 | 2,500 |
| 2012-12-22 00:57 | 2012-12-19 | CYTX | PLUS THERAPEUTICS, INC. | RICKEY DAVID | Director | BUY | $2.85 | 32,000 | $91,200 | 158,101 |
| 2012-12-22 00:55 | 2012-12-19 | CYTX | PLUS THERAPEUTICS, INC. | Dean Lloyd H | Director | BUY | $2.85 | 25,000 | $71,250 | 40,000 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.